Page last updated: 2024-10-24

chlordiazepoxide and Myasthenia Gravis

chlordiazepoxide has been researched along with Myasthenia Gravis in 1 studies

Chlordiazepoxide: An anxiolytic benzodiazepine derivative with anticonvulsant, sedative, and amnesic properties. It has also been used in the symptomatic treatment of alcohol withdrawal.
chlordiazepoxide : A benzodiazepine that is 3H-1,4-benzodiazepine 4-oxide substituted by a chloro group at position 7, a phenyl group at position 5 and a methylamino group at position 2.

Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tan, RS1

Other Studies

1 other study available for chlordiazepoxide and Myasthenia Gravis

ArticleYear
Ulcerative colitis, myasthenia gravis, atypical lichen planus, alopecia areata, vitiligo.
    Proceedings of the Royal Society of Medicine, 1974, Volume: 67, Issue:3

    Topics: Adult; Alopecia Areata; Autoantibodies; Biopsy; Chlordiazepoxide; Colitis, Ulcerative; Humans; Immun

1974